Applied DNA Expands BioPharm Vertical with Two New Research Pilots of DNA Therapeutics
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Business Wire
Unique PCR-based bulk DNA manufacturing offers purity, simplicity and speed to developers of DNA-based therapeutics; company seeing growing interest from market participants as awareness of proprietary processes increases STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA”, “the Company”), has begun initial Research and Development pilots for the manufacture of DNA for use in DNA-based therapeutics for two companies. Several other companies have requested proposals for additional DNA-based therapeutics. In one project, the Company is engaged in evaluation of a DNA therapeutic with a US-based customer and in the second, the Company is conducting an evaluation of two animal vaccines with Evvivax srl, an Italian biotech company focused on healthcare for companion animals. These pilots will be developed using the Company’s proprietary and patented large-scale PCR
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start [Yahoo! Finance]Yahoo! Finance
APDN
Earnings
- 2/8/24 - Beat
APDN
Sec Filings
- 4/19/24 - Form 8-K
- 4/16/24 - Form 8-K
- 3/21/24 - Form EFFECT
- APDN's page on the SEC website